Revenue grew 28.1% but operating cash swung negative on inventory build

EBITDA reached $0.5m, up $0.2m on HY25. However, operating cash flow swung from a $0.006m inflow to a $0.487m outflow, driven by a $1.4m increase in operating working capital. Inventory rose 133.8% to $1.9m and trade debtors rose 33.1% to $1.4m. Cash fell 13.5% to $3.0m. By channel, B2B contributed ~68% of revenue ($5.3m) and B2C 31.3% ($2.4m).

Cash conversion (OCF/EBITDA) was -97.4% versus +2.0% in HY25 and free cash flow of approximately -$0.6m converted at -136.0% of NPAT. The economic read is that none of the reported earnings translated into cash this half, which directly contradicts the "underlying earnings growth" framing in the release. This matters because the income statement and cash statement are telling different stories about the same six months.

Inventory build dominates the working-capital movement. Inventory is $1.1m higher than HY25 and explains most of the $1.4m working-capital absorption. Without disclosed commentary on whether this represents pre-positioning for a seasonally stronger second half or accumulation of slower-moving stock, the durability of the implied margin is harder to assess. Debtor days at 32.9 sit within Annolyse's historical baseline (range 21.6-37.9, mean 30.4), so the receivables movement is not the structural concern.

Revenue growth and PBT margin are running above the historical baseline. Revenue growth of 28.1% exceeds the 3-period historical mean of 15.6% (range 10.2%-25.4%), and the 5.2% PBT margin is above the historical range and the -16.4% mean. The income-statement shift is genuinely better than recent history; the question is whether it sustains once the cash gap is reconciled.

Annualising HY26 revenue gives $15.3m, but applying the prior shape implies a stronger full-year revenue outturn. No company-stated targets are provided.

The release notes a further $0.1m of one-off costs to be released, implying some additional cost normalisation in 2H, and the inventory build may be deliberate positioning for the heavier half. Whether 2H revenue and cash conversion follow the historical pattern is the central uncertainty this release does not resolve.

The 5.6% effective tax rate is close to the 8.0% prior comparable, so PBT growth of +100.0% is the cleaner operating read and is not tax-distorted. PBT margin moved from a historical mean of -16.4% into a 5.2% surplus, which is a structural rather than presentational shift.

The cash-quality gap is the offset. Reported NPAT of $0.4m converted to roughly -$0.6m of free cash flow, with capex of $0.083m (1.1% of revenue) a small contributor. The dominant driver is the $1.4m working-capital absorption, of which inventory is roughly $1.1m. If the inventory unwinds into 2H sales at expected margins, cash quality should recover and the $3.0m cash balance is adequate; if it represents structural stocking-up or cover for slower turnover, near-term liquidity tightens. The release also references $1.3m of "underlying" EBITDA excluding one-off costs, which is a non-GAAP figure and should be treated as management framing, not as a reconciled measure of recurring earnings.

This briefing cannot assess whether the inventory build is positioning for 2H demand or evidence of slowing sell-through, because the release does not disclose stock composition or order cover.